Search by Drug Name or NDC

    NDC 55111-0739-27 Lansoprazole 15 mg/1 Details

    Lansoprazole 15 mg/1

    Lansoprazole is a ORAL CAPSULE, DELAYED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Dr. Reddy's Laboratories Limited. The primary component is LANSOPRAZOLE.

    Product Information

    NDC 55111-0739
    Product ID 55111-739_6065013b-122b-95f2-fe85-e34d8eaf89d2
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Lansoprazole
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lansoprazole
    Product Type HUMAN OTC DRUG
    Dosage Form CAPSULE, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 15
    Active Ingredient Units mg/1
    Substance Name LANSOPRAZOLE
    Labeler Name Dr. Reddy's Laboratories Limited
    Pharmaceutical Class Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA202194
    Listing Certified Through 2024-12-31

    Package

    NDC 55111-0739-27 (55111073927)

    NDC Package Code 55111-739-27
    Billing NDC 55111073927
    Package 2 BOTTLE in 1 CARTON (55111-739-27) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE
    Marketing Start Date 2019-08-19
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 15e05eda-48aa-a4b7-4b8a-4ee1cf110120 Details

    Revised: 7/2019